Home » Topics » BioWorld Science

BioWorld Science
RSS

Mitsubishi Tanabe Pharma reviews developments of third quarter of fiscal 2017

Feb. 7, 2018

IND for anti-PD-L1 antibody STI-A1015 cleared in South Korea

Feb. 7, 2018

Silver Creek Pharmaceuticals completes financing to advance SGF-1

Feb. 7, 2018

Dose modification on MM-398 plus 5-FU/LV does not impact survival

Feb. 7, 2018

FDA gives RMAT designation to Capricor's CAP-1002 for DMD

Feb. 7, 2018

Pembrolizumab plus rhuGM-CSF found safe in patients with advanced biliary cancer

Feb. 7, 2018

Eisai reviews milestones of third quarter of fiscal 2017

Feb. 7, 2018

Incyte discovers new PD-1/PD-L1 interaction inhibitors

Feb. 6, 2018

Italfarmaco divulges novel benzo-N-hydroxy amide compounds

Feb. 6, 2018

New isocitrate dehydrogenase inhibitors described by Nanjing Sanhome Pharmaceutical

Feb. 6, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 13, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...